Zealand Pharma A/S
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Zealand Pharma A/S's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 17% to $292,567,000. Profit margin reached -348%. Total operating expenses were $1,223,950,000.
Profit Margin
| 2012 | 223.56M | 36.37M | 16.27% |
|---|---|---|---|
| 2013 | 6.57M | -183.67M | -2793.98% |
| 2014 | 153.77M | -64.99M | -42.26% |
| 2015 | 187.67M | -113.95M | -60.72% |
| 2016 | 234.77M | -153.91M | -65.56% |
| 2017 | 139.77M | -272.27M | -194.79% |
| 2018 | 37.97M | 581.28M | 1530.62% |
| 2019 | 41.33M | -571.54M | -1382.77% |
| 2020 | 353.31M | -846.72M | -239.65% |
| 2021 | 292.56M | -1.01B | -348.01% |
ZEAL Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 292.56M | 353.31M | 41.33M | 37.97M | 139.77M | 234.77M | 187.67M | 153.77M | 6.57M | 223.56M |
Cost of revenue | 118.81M | 90.56M | 415K | 180.23M | 14.62M | 31.45M | 22.26M | 13.77M | 872K | 15.93M |
Gross profit | 173.75M | 262.74M | 40.91M | -142.26M | 125.14M | 203.31M | 165.41M | 139.99M | 5.70M | 207.63M |
Operating exp. | ||||||||||
Research and development | 588.45M | 604.08M | 561.42M | 438.21M | 324.66M | 268.15M | 214.95M | 180.03M | 164.46M | 182.75M |
Selling and marketing | 375.26M | 285.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.22B | 1.09B | 628.86M | 515.58M | 371.53M | 318.96M | 246.73M | 213.53M | 191.32M | 175.23M |
Operating income | -1.02B | -792.36M | -587.94M | 652.39M | -246.38M | -115.64M | -81.32M | -73.53M | -185.61M | 32.39M |
Other income (expenses), net | -4.09M | -47.29M | 11.26M | -27.33M | -31.38M | -43.76M | -38.50M | 1.04M | 1.94M | 3.97M |
Income before tax | -1.02B | -839.65M | -576.67M | 625.05M | -277.77M | -159.41M | -119.83M | -72.49M | -183.67M | 36.37M |
Income tax expense | -8.79M | 7.07M | -5.13M | 43.77M | -5.5M | -5.5M | -5.87M | -7.5M | 2.02M | 0 |
Net income | -1.01B | -846.72M | -571.54M | 581.28M | -272.27M | -153.91M | -113.95M | -64.99M | -183.67M | 36.37M |
Earnings per share | ||||||||||
Basic EPS | -26.54 | -22.07 | -16.91 | 18.94 | -9.77 | -6.33 | -4.82 | -2.87 | -8.12 | 1.61 |
Diluted EPS | -26.54 | -22.07 | -16.91 | 18.94 | -9.77 | -6.33 | -4.82 | -2.87 | -8.12 | 1.6 |
| Data source | Data source | Data source | Data source | Data source |